Stock listing
OTC:PFSF Pacific Software, Inc. Stock
Follow Pacific Software, Inc. into a list and get an email when it puts out news.
Share price · OTC:PFSF
$0.03 USD -0.02 (-39.4%)
Close on Nov 20, 2026
- Day range
- $0.03 – $0.03 USDNov 20, 2026
- Volume
- 100,000 sharesNov 20, 2026
- Market cap
- $29.86M USDAt the close on Nov 20, 2026 · price × 995.4M shares outstanding
- 52-week range
- $0.0088 – $0.125 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $7,532 USDMedian day 31,149 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:PFSF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.03 | -0.02 | -39.4% | $0.03 | $0.03 | $0.03 | 100,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | +0.005 | +10.0% | $0.04 | $0.05 | $0.04 | 103,182 | |
| $0.045 | -0.005 | -10.0% | $0.045 | $0.045 | $0.045 | 1,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 4,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | +0.02 | +66.7% | $0.049 | $0.05 | $0.03 | 880,016 | |
| $0.03 | +0.002 | +7.1% | $0.03 | $0.049 | $0.03 | 1,029,333 | |
| $0.028 | -0.017 | -37.8% | $0.03 | $0.03 | $0.028 | 758,225 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 3,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 3,000 | |
| $0.045 | +0.005 | +12.5% | $0.025 | $0.045 | $0.025 | 1,200 | |
| $0.04 | -0.009 | -18.4% | $0.04 | $0.04 | $0.04 | 50,000 | |
| $0.049 | +0.009 | +22.5% | $0.049 | $0.049 | $0.049 | 6,000 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | -0.01 | -20.0% | $0.04 | $0.045 | $0.04 | 463,811 | |
| $0.05 | -0.015 | -23.1% | $0.05 | $0.05 | $0.04 | 110,405 | |
| $0.065 | 0.00 | 0.0% | $0.065 | $0.065 | $0.065 | 3,000 | |
| $0.065 | +0.025 | +62.5% | $0.05 | $0.065 | $0.04 | 139,999 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 100,000 | |
| $0.04 | -0.009 | -18.4% | $0.04 | $0.04 | $0.04 | 205,800 | |
| $0.049 | -0.001 | -2.0% | $0.05 | $0.05 | $0.049 | 2,954 | |
| $0.05 | +0.01 | +25.0% | $0.04 | $0.05 | $0.04 | 13,300 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | -0.01 | -20.0% | $0.04 | $0.04 | $0.04 | 209,400 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | +0.002 | +4.2% | $0.05 | $0.05 | $0.04 | 170,500 | |
| $0.048 | -0.002 | -4.0% | $0.05 | $0.05 | $0.048 | 52,500 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.047 | 23,297 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 1,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.045 | 219,500 | |
| $0.05 | +0.001 | +2.0% | $0.05 | $0.05 | $0.05 | 1,000 | |
| $0.049 | 0.00 | 0.0% | $0.049 | $0.049 | $0.049 | 0 | |
| $0.049 | -0.001 | -2.0% | $0.05 | $0.05 | $0.049 | 100,000 | |
| $0.05 | -0.02 | -28.4% | $0.08 | $0.08 | $0.049 | 1,121,600 | |
| $0.07 | +0.005 | +7.4% | $0.065 | $0.08 | $0.065 | 6,500 | |
| $0.065 | +0.016 | +32.7% | $0.065 | $0.065 | $0.065 | 1,000 | |
| $0.049 | -0.011 | -18.3% | $0.05 | $0.05 | $0.049 | 215,000 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 0 | |
| $0.06 | -0.02 | -24.8% | $0.031 | $0.06 | $0.014 | 135,505 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 100 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 0 | |
| $0.08 | +0.02 | +33.0% | $0.059 | $0.08 | $0.059 | 20,100 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 276,000 | |
| $0.06 | +0.01 | +20.0% | $0.06 | $0.06 | $0.059 | 103,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 684,000 | |
| $0.05 | +0.001 | +2.0% | $0.05 | $0.05 | $0.05 | 1,300,000 | |
| $0.049 | +0.004 | +8.9% | $0.05 | $0.05 | $0.049 | 169,100 | |
| $0.045 | -0.005 | -10.0% | $0.06 | $0.06 | $0.045 | 181,000 | |
| $0.05 | -0.01 | -16.7% | $0.051 | $0.06 | $0.05 | 84,000 | |
| $0.06 | 0.00 | 0.0% | $0.065 | $0.08 | $0.059 | 783,072 | |
| $0.06 | -0.02 | -24.8% | $0.08 | $0.08 | $0.06 | 55,000 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 5,000 | |
| $0.08 | 0.00 | 0.0% | $0.052 | $0.08 | $0.052 | 10,000 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 5,000 | |
| $0.08 | 0.00 | -0.1% | $0.08 | $0.08 | $0.0088 | 110,000 | |
| $0.08 | +0.001 | +0.6% | $0.08 | $0.08 | $0.08 | 5,000 | |
| $0.079 | +0.019 | +32.3% | $0.08 | $0.08 | $0.079 | 11,200 | |
| $0.06 | +0.003 | +5.3% | $0.06 | $0.06 | $0.06 | 10,400 | |
| $0.057 | -0.001 | -1.7% | $0.058 | $0.058 | $0.057 | 39,000 | |
| $0.058 | +0.008 | +16.0% | $0.057 | $0.058 | $0.057 | 10,000 | |
| $0.05 | -0.008 | -13.8% | $0.054 | $0.054 | $0.05 | 110,000 | |
| $0.058 | 0.00 | 0.0% | $0.058 | $0.058 | $0.058 | 700 | |
| $0.058 | +0.008 | +16.0% | $0.06 | $0.06 | $0.055 | 146,085 | |
| $0.05 | -0.01 | -16.7% | $0.05 | $0.06 | $0.05 | 151,750 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 10,101 |
Splits
1 split · OTC:PFSF · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- OTC:PFSF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
PurMinds Announces Clinical Validation Collaboration with SpectroChip and Taiwan's Kaohsiung Municipal Siaogang Hospital
Latest news
PurMinds Announces Clinical Validation Collaboration with SpectroChip and Taiwan's Kaohsiung Municipal Siaogang Hospital
Oct 14, 2026
Closed $0.05 (+4.2%) on Oct 15, 2026
PurMinds Enterprises, Inc. Files Fiscal 2026 Second Quarter Financials on OTC Markets; Launches PCAOB Audit to Position for OTCQB/QX Uplisting
Jun 12, 2026
Closed $0.043 (-14.0%) on Jun 12, 2026
PurMinds Enterprises, Inc. (Formerly Pacific Software, Inc.) Appoints Angelo Pizzuto as CFO, COO, Secretary, and Treasurer to Lead PCAOB Audit and Commercialization Phase
Jun 10, 2026
Closed $0.05 (+19.0%) on Jun 11, 2026
Pacific Software, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 4 in the last 12 months · 33 in all · newest Oct 14, 2026 · oldest 2010
Valuation
Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $38.10M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 1.57
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Pacific Software, Inc. · OTC:PFSF | US$29.86M | US$38.10M | n/a | n/a | n/a | n/a | n/a | n/a | 1.57 |
| Caribou Biosciences, Inc. · NASDAQ:CRBU | US$30.71M | −US$37.75M | n/a | −4.0× | n/a | 0.4× | n/a | 0.3× | 1.87 |
| Avecho Biotechnology Limited · ASX:AVE | US$30.69M | US$26.46M | n/a | 32.3× | n/a | 24.3× | −356.8% | 0.1× | n/a |
| Kalaris Therapeutics, Inc. · NASDAQ:KLRS | US$30.47M | −US$51.05M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | 0.47 |
| NextCure, Inc. · NASDAQ:NXTC | US$29.53M | US$20.81M | n/a | n/a | n/a | 5.4× | n/a | 0.0× | 1.85 |
| NurExone Biologic Inc · TSXV:NRX | US$29.52M | US$28.52M | n/a | n/a | n/a | 23.3× | n/a | 0.0× | 0.00 |
| BioHarvest Sciences, Inc. · NASDAQ:BHST | US$29.47M | US$34.54M | n/a | 1.0× | n/a | 1.8× | −34.7% | 1.0× | 0.43 |
| Thiogenesis Therapeutics Corp · TSXV:TTI | US$29.28M | US$24.21M | n/a | n/a | n/a | 6.2× | n/a | 0.0× | 0.37 |
| NanoViricides, Inc. · AMEX:NNVC | US$29.11M | US$26.54M | n/a | n/a | n/a | 4.5× | n/a | 0.0× | 1.82 |
| Rein Therapeutics, Inc. · NASDAQ:RNTX | US$29.06M | −US$6.43M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | 2.11 |
| Nicox SA · EURONEXT:ALCOX | US$29.05M | US$25.67M | n/a | 1.4× | n/a | 3.8× | −14.4% | 0.4× | n/a |
| Median of the others | US$29.50M | US$24.94M | 1.2× | 4.2× | −34.7% | 0.0× | 1.15 |
Team and board
| Officer | Role |
|---|---|
| Angelo Pizzuto | CFO, COO, Secretary |
Events
| Quarter | Results |
|---|---|
| Quarter to Mar 31, 2021 | Jun 30, 2021 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.31M | 3.03M | 3.40M | 20.0K | 70.0K | 0 | 0 | 0 | ||
| Cost of revenue | 606.2K | 1.68M | 901.9K | 5.00K | 69.9K | 60.0K | 0 | 0 | ||
| Gross profit | 705.5K | 1.36M | 2.50M | 15.0K | 70 | -60.0K | 0 | 0 | ||
| Research and development | 0 | 0 | ||||||||
| Selling, general and administrative | 220.2K | 1.16M | 2.92M | 99.6K | ||||||
| Operating income | -98.1K | -411.0K | -1.01M | -4.19M | -961.0K | -495.2K | -22.5M | -3.73M | -99.6K | |
| Depreciation and amortization | 57.1K | 341.6K | 118.0K | 172.2K | 22.5M | 3.72M | 99.6K | |||
| EBITDA | -949.9K | -3.85M | -843.0K | -323.0K | -33 | -1.88K | 0 | |||
| Interest expense | 13.9K | 867.1K | 1.54M | 11.8M | 5.43K | 829 | 0 | 0 | 0 | |
| Income before tax | -74.2K | -424.0K | -14.2M | 17.7M | -4.23M | -21.5M | -21.1M | -3.73M | -112.3K | -15.2K |
| Income tax | -1.43M | -222.0K | -59.9K | 2.45K | -22.5K | -3.72M | -99.6K | 0 | ||
| Net income | -74.2K | -424.0K | -12.7M | 18.0M | -4.17M | -21.5M | -21.1M | -3.73M | -112.3K | -15.2K |
| Earnings per share, basic | -0.00 | -0.01 | -0.58 | 0.94 | -0.22 | -1.12 | -1.70 | -0.30 | -0.07 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 108 | 32.3K | 2.32K | 643.0K | 690.8K | 80.5K | 108.8K | 934.2K | 4 | |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 8.27K | 20.0K | ||||||||
| Inventory | 40.3K | 84.6K | 56.8K | 0 | 0 | |||||
| Current assets | 108 | 32.3K | 2.32K | 844.6K | 1.16M | 502.7K | 414.5K | 1.04M | 4 | |
| Property, plant and equipment | 1.98M | 0 | 0 | |||||||
| Goodwill | 0 | 0 | ||||||||
| Total assets | 108 | 4.76M | 2.32K | 6.33M | 3.41M | 2.54M | 637.7K | 1.04M | 4 | |
| Accounts payable | 46.3K | 53.6K | 1.76M | 851.5K | 292.6K | 16.3K | 0 | 0 | 187.9K | |
| Current liabilities | 480.3K | 781.4K | 310.0K | 11.1M | 25.3M | 21.4M | 58.2K | 45.1K | 276.1K | 187.9K |
| Long-term debt | 0 | 0 | ||||||||
| Total debt | 300.0K | 510.0K | 300.0K | 10.9M | 19.6M | 7.22M | 8.29K | 8.29K | 105.9K | |
| Total liabilities | 480.3K | 781.4K | 310.0K | 12.9M | 27.1M | 22.3M | 58.2K | 45.1K | 276.1K | 187.9K |
| Shareholders' equity | -480.0K | 3.98M | -307.7K | -6.60M | -24.2M | -20.3M | 579.5K | 994.8K | -276.1K | |
| Shares outstanding | 47.3M | 40.5M | 22.0M | 19.2M | 19.2M | 19.2M | 12.4M | 12.4M | 1.68M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -165.1K | -164.4K | -1.90M | -2.08M | -1.19M | -78.3K | -1.20M | -1.47M | -92 | |
| Capital spending | -1 | -164.4K | -285.9K | -1.49M | -103.6K | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | -165.1K | -328.8K | -2.18M | -3.57M | -1.29M | -78.3K | -1.20M | -1.47M | -92 | |
| Cash from investing | 132.9K | 18.9K | -545.4K | -1.49M | -103.6K | 50.0K | 50.0K | 50.0K | 50.0K | |
| Cash from financing | -3 | 175.5K | 1.80M | 3.47M | 1.90M | 33.6K | 370.0K | 2.40M | 96 | |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 0 | 0 | ||||||||
| Change in cash | -32.2K | 30.0K | -640.7K | -47.8K | 610.2K | -28.3K | -825.4K | 934.2K | 4 |
Cap table
Built by 6ix from Pacific Software, Inc.’s releases
- Common shares
- 995,425,409
- Fully diluted
- 995,425,409
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 995,425,409 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 995,425,409 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Angelo Pizzuto | CFO, COO, Secretary · Since at least Jun 10, 2026 |
| Bruce Thomsen | President, Secretary, Director · Jun 1, 2010 – Jun 1, 2010 · Past |
| Harrysen Mittler | President/Secretary, Director · Dec 3, 2009 – Dec 3, 2009 · Past |
Log in to ask 6ix AI your own questions about Pacific Software, Inc.